This inventor holds 1 USPTO granted patent. Top assignee: Washington University. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Alexander David Barrow: Innovator in Natural Cytotoxicity Receptor Modulation
Introduction
Alexander David Barrow is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of immunology, particularly in the modulation of natural cytotoxicity receptors.
Latest Patents
Barrow holds a patent for the "Activation of natural cytotoxicity receptor 2 (NCR2)." This patent encompasses methods and compositions aimed at modulating the Natural Cytotoxicity Receptor 2, which plays a crucial role in the immune response.
Career Highlights
Barrow is affiliated with Washington University, where he engages in research that advances our understanding of immune mechanisms. His work has implications for developing therapies that enhance immune responses against various diseases.
Collaborations
One of his notable collaborators is Marco Colonna, a prominent figure in the field of immunology. Their partnership has contributed to the advancement of research in natural cytotoxicity receptors.
Conclusion
Alexander David Barrow's innovative work in modulating NCR2 highlights his contributions to immunology and the potential for new therapeutic approaches. His research continues to pave the way for advancements in immune system modulation.